Toronto: Antiviral drug, Paxlovid, significantly reduced the likelihood of hospitalisation or death from COVID-19 in people at risk of severe illness during the Omicron wave, according to a study. The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of Paxlovid, a combination of nirmatrelvir and ritonavir drugs, in preventing severe […]
